Vendor and Supplier Qualification Program for FDA Regulated Industries Vendor and Supplier Qualification Program for FDA Regulated Industries Seminar has been added to ComplianceOnline.com s offering.
SAN JOSE, CALIFORNIA, UNITED STATES, April 19, 2021 /EINPresswire.com/ ComplianceOnline, the world’s leading provider of training for regulated companies will hold a virtual seminar entitled ‘Vendor and Supplier Qualification Program for FDA Regulated Industries.’ The seminar which will be presented by Joy McElroy, will help attendees establish and manage a program that is FDA compliant and robust.
The FDA regulates manufacturers of medical products such as devices, pharmaceuticals, tissue products, and biologics. However, the regulations don’t usually extent to suppliers. Instead, the FDA expects the medical product manufacturer to implement an effective program to qualify and re-qualify suppliers for these regulated industries.
ComplianceOnline Hosts ‘Cleanroom, Microbiology & Sterility Assurance Practices Seminar for Drug & Device Manufacturers’
News Provided By
Share This Article
Cleanroom, Microbiology and Sterility Assurance Practices for Drug and Device Manufacturers Cleanroom, Microbiology and Sterility Assurance Practices for Drug and Device Manufacturers Seminar has been added to ComplianceOnline.com s offering.
SAN JOSE, CA, UNITED STATES, April 15, 2021 /EINPresswire.com/ ComplianceOnline, the world’s leading provider of regulatory compliance training, is holding a 2-day virtual seminar entitled ‘Cleanroom, Microbiology and Sterility Assurance Practices for Drug and Device Manufacturers’ on May 10-11, 2021 (9:00 AM to 4:00 PM EDT). The seminar will be presented by Charity Ogunsanya, CEO and Founder, Pharmabiodevice Consulting LLC.
Top 10 Most-Cited MHRA GMP Inspection Deficiencies By Annex/Chapter In 2019
We evaluated the U.K. Medicines and Healthcare products Regulatory Agency’s (MHRA) GMP inspection data for 2019, including trends associated with prior years, in Part 1 of this two-part article. We also addressed the critical and major deficiencies and the annexes and chapters with which they are associated. In this part, we take the 10 chapters and annexes with the highest numbers of deficiencies and do a deeper dive into the specifics of each.
In the figures that follow, we identify the paragraphs that were cited most frequently for each of the 10 chapters and annexes identified in Figure 1 of part 1 of this series. For two of these, Chapter 1 and Annex 15, we provide two figures for each because a handful of the paragraphs dominate the deficiencies in those areas. The following figures include
P-345 Pharma Microbiology EC
SMi Reports Two exclusive interviews with Lacey Batts at Novo Nordisk and Joanny Salvas at Pfizer speaking at 4th Annual Pharma Microbiology East Coast released BOSTON, MA, UNITED STATES, February 11, 2021 /EINPresswire.com/ The Pharmaceutical Microbiology Conference East Coast Virtual Conference will be commencing on 28th and 29th April 2021 and will focus on implementing robust sterility assurance strategies for effective contamination control.
SMi Group caught up with Lacey Batts, QC Biochemist II, QC Microbiology & Biochemistry T Novo Nordisk and Joanny Salvas, Manager, PAT Projects at Pfizer. Lacey Batts as a Biochemist II (Microbiologist II) in QC at Novo Nordisk Pharmaceutical-Site Clayton, works with the Cleaning Validation team (as well the Clean Utilities team) as the direct representative for all water testing. Lacey aids in planning and preparation for all current and future cleaning validation act